289 related articles for article (PubMed ID: 26307432)
1. The C-C chemokine receptor 6 (CCR6) is crucial for Th2-driven allergic conjunctivitis.
Chung SH; Chang SY; Lee HJ; Choi SH
Clin Immunol; 2015 Dec; 161(2):110-9. PubMed ID: 26307432
[TBL] [Abstract][Full Text] [Related]
2. Superoxide dismutase 3 attenuates experimental Th2-driven allergic conjunctivitis.
Lee HJ; Kim BM; Shin S; Kim TY; Chung SH
Clin Immunol; 2017 Mar; 176():49-54. PubMed ID: 28063939
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 4 signalling attenuates experimental allergic conjunctivitis.
Chung SH; Choi SH; Cho KJ; Joo CK
Clin Exp Immunol; 2011 May; 164(2):275-81. PubMed ID: 21391988
[TBL] [Abstract][Full Text] [Related]
4. Curcumin suppresses ovalbumin-induced allergic conjunctivitis.
Chung SH; Choi SH; Choi JA; Chuck RS; Joo CK
Mol Vis; 2012; 18():1966-72. PubMed ID: 22876123
[TBL] [Abstract][Full Text] [Related]
5. A functional role for CCR6 on proallergic T cells in the gastrointestinal tract.
Blázquez AB; Knight AK; Getachew H; Bromberg JS; Lira SA; Mayer L; Berin MC
Gastroenterology; 2010 Jan; 138(1):275-84.e1-4. PubMed ID: 19782082
[TBL] [Abstract][Full Text] [Related]
6. Topical Application of Interleukin-28A Attenuates Allergic Conjunctivitis in an Ovalbumin-Induced Mouse Model.
Chen J; Zhang J; Zhao R; Jin J; Yu Y; Li W; Wang W; Zhou H; Su SB
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):604-10. PubMed ID: 26886894
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin attenuates Th2-driven experimental allergic conjunctivitis.
Shin S; Lee JH; Lee HJ; Chang SY; Chung SH
Clin Immunol; 2018 May; 190():1-10. PubMed ID: 29432811
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice.
Bellinghausen I; Sudowe S; König B; Reske-Kunz AB; Knop J; Saloga J
Int Arch Allergy Immunol; 2006; 141(1):61-9. PubMed ID: 16804328
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus accelerates an experimental allergic conjunctivitis by Toll-like receptor 2-dependent manner.
Chung SH; Nam KH; Kweon MN
Clin Immunol; 2009 Apr; 131(1):170-7. PubMed ID: 19358332
[TBL] [Abstract][Full Text] [Related]
10. Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4.
Kaminuma O; Ohtomo T; Mori A; Nagakubo D; Hieshima K; Ohmachi Y; Noda Y; Katayama K; Suzuki K; Motoi Y; Kitamura N; Saeki M; Nishimura T; Yoshie O; Hiroi T
Clin Exp Allergy; 2012 Feb; 42(2):315-25. PubMed ID: 22092376
[TBL] [Abstract][Full Text] [Related]
11. Isolated Schistosoma mansoni eggs prevent allergic airway inflammation.
Obieglo K; Schuijs MJ; Ozir-Fazalalikhan A; Otto F; van Wijck Y; Boon L; Lambrecht BN; Taube C; Smits HH
Parasite Immunol; 2018 Oct; 40(10):e12579. PubMed ID: 30107039
[TBL] [Abstract][Full Text] [Related]
12. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
[TBL] [Abstract][Full Text] [Related]
13. 15-lipoxygenase metabolites play an important role in the development of a T-helper type 1 allergic inflammation induced by double-stranded RNA.
Jeon SG; Moon HG; Kim YS; Choi JP; Shin TS; Hong SW; Tae YM; Kim SH; Zhu Z; Gho YS; Kim YK
Clin Exp Allergy; 2009 Jun; 39(6):908-17. PubMed ID: 19260872
[TBL] [Abstract][Full Text] [Related]
14. Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis.
Schlereth S; Lee HS; Khandelwal P; Saban DR
Am J Pathol; 2012 Jun; 180(6):2351-60. PubMed ID: 22507838
[TBL] [Abstract][Full Text] [Related]
15. Topical Administration of β-1,3-Glucan to Modulate Allergic Conjunctivitis in a Murine Model.
Lee HS; Kwon JY; Joo CK
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1352-60. PubMed ID: 27002295
[TBL] [Abstract][Full Text] [Related]
16. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
Comerford I; Bunting M; Fenix K; Haylock-Jacobs S; Litchfield W; Harata-Lee Y; Turvey M; Brazzatti J; Gregor C; Nguyen P; Kara E; McColl SR
Bioessays; 2010 Dec; 32(12):1067-76. PubMed ID: 20954179
[TBL] [Abstract][Full Text] [Related]
17. Mice vaccinated with allergen-pulsed myeloid dendritic cells are not protected from developing allergen-induced Th2 responses.
Trujillo-Vargas CM; Ramirez-Pineda JR; Palmetshofer A; Grunewald S; Moll H; Berberich C; Erb KJ
Int Arch Allergy Immunol; 2005 Jul; 137(3):219-28. PubMed ID: 15956790
[TBL] [Abstract][Full Text] [Related]
18. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
19. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
20. The adjuvant-like activity of staphylococcal enterotoxin B in a murine asthma model is independent of IL-1R signaling.
Krysko O; Maes T; Plantinga M; Holtappels G; Imiru R; Vandenabeele P; Joos G; Krysko DV; Bachert C
Allergy; 2013 Apr; 68(4):446-53. PubMed ID: 23347053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
